📰 Risk Stratification News
Page 2 - Risk Stratification News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Risk Stratification. Real-time updates on events, politics, business and more.
January 15, 2024
Medical experts dissect critical strategies for monitoring for potential adverse events with bispecific antibodies in a comprehensive panel discussion.
January 12, 2024
Considerations for enhancing bispecific drug effectiveness through strategic EMR utilization in healthcare are explored.
January 12, 2024
A panel discussion covers considerations within REMS programs aimed at minimizing risks associated with bispecific therapy. NOTE: Not all FDA-approved bispecific antibodies are associated with a REMS protocol.
January 12, 2024
Providers delve into considerations for continuation of optimal care when patients receiving bispecific therapy transition between care settings.
December 9, 2023
Michael D. Shapiro, DO, reviews and discusses the different guidelines and recommendations on Lp(a) testing.
December 8, 2023
With the FDA clearance, the company is now able to commercially provide the AI solution to medical professionals and healthcare institutions in the U.S.
December 7, 2023
122 Patients Enrolled in Single-arm IDE Study; 30-Day Follow-up ...
December 7, 2023
AngioDynamics, Inc. , a leading and transformative medical technology company focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving patient quality of life, today announced the...
December 6, 2023
/PRNewswire/ -- Bering Limited, a London-based medical AI company, today announced it received US Food and Drug Administration (FDA) 510(k) clearance for its...
November 30, 2023
Dr. Ronjon Paul, a spine surgeon with Edward-Elmhurst Health, discusses how healthcare technology is entering a new era of innovation with an increased focus on patient-centered care.